NSAID Safety Review Prompts MHRA To Pursue Product Label Updates
This article was originally published in The Tan Sheet
Executive Summary
Following a review of newly available data on the cardiovascular safety of NSAIDs, UK and European Union health authorities have diverged somewhat in their recommendations for the drug category going forward